Real-Time Molecular Sensing Heralds New Era Of Continuous Monitoring
The Case For DNA Aptamer-Based Sensors In Monitoring Vancomycin Concentrations And Creatinine Levels In Real-Time
The traditional method of performing conventional lab diagnostic testing, using blood draws and waiting often long periods for the results, presents challenges for clinicians dealing with complex medical conditions. Continuous diagnostic monitoring based on real-time molecular sensing is the long-awaited solution.
Continuous Glucose Monitors have demonstrated the power of real-time information in treating patients • Source: Shutterstock
A major drawback of the current process of lab diagnostic testing is that it lacks the ability to factor in trend data and real-time insights that allow for the informed decisions that doctors now more frequently require.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
Appointed CEO 12 months ago, Anthony Costello wasted no time in orchestrating strategic change at Medidata. He talked to In Vivo about the art of the pivot and how to constantly push boundaries.
The integration of digital health tools into clinical research and patient care is gaining momentum, and Merck KGaA, Darmstadt, Germany is not letting the grass grow under its feet. With an approach to digital biomarkers, the company is seeking to redefine how neurological diseases are monitored and managed.
In Vivo spoke with Catherine Pickering, the CEO and founder of iOnctura, a UK-based clinical stage biotech company developing therapies for uveal melanoma and other hard-to-treat cancers by disrupting the tumor-stroma-immune interface.
Capital remains available for good healthtech projects, but it is more concentrated and harder to find than of late. Founders and inventors must know how to unlock it. The BioWales 2025 investor panel told them where they could be going wrong.
Appointed CEO 12 months ago, Anthony Costello wasted no time in orchestrating strategic change at Medidata. He talked to In Vivo about the art of the pivot and how to constantly push boundaries.
